Pioneering medtech business ONWARD has revealed it is managing to mitigate the global supply chain challenges, enabling it to remain on course for commercialisation of its groundbreaking spinal cord stimulation therapy.
Worldwide microprocessor shortages and the scarcity of other components are expected to impact development timing for both of the company’s technology platforms – the ARC EX and ARC IM – but with minimised impact, which the business credits as being due to its strong cash position.
The ARC EX is now expected to be ready for commercialisation in late 2023, with the ARC IM set to be commercialised in late 2025.
The technology, developed to enable people living with spinal cord injury to regain independence, movement and improved health, has shown its life-changing impact through recent and ongoing trials.
Its STIMO-BRIDGE trial, using the ARC IM for the first time in humans, saw three participants regaining the ability to take steps the day after the epidural electronic stimulation (EES), and after five months of rehabilitation, were also able to stand, walk, run and swim.
The ongoing Up-LIFT trial of its ARC EX platform, which completed its enrolment of 65 participants despite the many challenges presented by COVID, is already delivering positive indications.
But now, despite the potentially significant delays affecting other businesses, ONWARD said its current cash balance could fuel operations to the end of 2024, enabling its development can continue to progress.
“Many companies and industries have been affected by supply chain challenges,” says Dave Marver, CEO of ONWARD.
“To limit our downside, we have worked with determination to source critical components and assure continuity of supply in order to fulfil our mission to help people with spinal cord injury live better lives.
“We have a strong balance sheet, with cash to propel operations through the end of 2024, and we will look for opportunities to further strengthen our cash position as equity capital markets improve in the US and across the globe.”
ONWARD’s work builds on more than a decade of science and preclinical research conducted at the world’s leading neuroscience laboratories.
ONWARD’s ARC Therapy suite, which can be delivered by implantable – ARC IM – or the external ARC EX systems, is designed to deliver targeted, programmed stimulation of the spinal cord to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
__cfduid
1 month
The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
_GRECAPTCHA
5 months 27 days
This cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics
This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
1 year
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
1 year
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Cookie
Duration
Description
_gat
1 minute
This cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cookie
Duration
Description
_ga
2 years
This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid
1 day
This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
iutk
5 months 27 days
This cookie is used by Issuu analytic system. The cookies is used to gather information regarding visitor activity on Issuu products.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Cookie
Duration
Description
NID
6 months
This cookie is used to a profile based on user's interest and display personalized ads to the users.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Cookie
Duration
Description
cookielawinfo-checkbox-functional
1 year
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others
No description
lfuuid
9 years 11 months
Third party (Lead Forensics) cookie which enables us to track visitor behaviour on our site. Tracking is performed anonymously until a user identifies themselves by submitting a form.